Loading
Everything OnCo dates to 1975: 17 entries, 8 landmarks, 3 journals founded, 2 papers listed on people's pages and 2 technologies. Each line links to the record it was read from, so the year is a view of the corpus rather than a second copy of it.
17 dated entries in OnCo fall in 1975: 8 landmarks, 3 journals founded, 2 papers listed on people's pages, 2 technologies, 1 approval and 1 paper.
Of those, 17 to the year only. Most of the corpus dates a fact to the year, because that is what the source it was read from gives; regulatory events and the readout calendar are the parts that carry a full date.
Everything on this page is generated from the other records. It holds no fact of its own, and it changes when they do.
The approvals rows on treatment records: region, year and indication.
Metastatic malignant melanoma; Hodgkin disease (second line, combination)
The publication year on key paper records.
Mintz B, Illmensee K. Proceedings of the National Academy of Sciences.
The history entries editors wrote on cancer records: the dated turning points of each disease.
Hodgkin lymphoma
Advanced-stage classical Hodgkin lymphoma (stage III to IV)
Extrahepatic cholangiocarcinoma (perihilar and distal)
Early-stage classical Hodgkin lymphoma (stage I to II)
Advanced melanoma (unresectable stage III and stage IV)
Melanoma
Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma)
Chronic lymphocytic leukaemia. Clinical staging by lymphocytosis, nodes, organomegaly, cytopenias; Binet system follows in 1981.
The since year on technology records: first use in humans or first approval, as the record states it.
First use in humans or first approval, as the technology record states it.
First use in humans or first approval, as the technology record states it.
The founded year on journal records.
Elsevier
Elsevier
Elsevier
The selected publications each biography lists, which is a reading of that person rather than a reading of the year.
European Journal of Immunology
Nature